Form 4: Xometry COO Peter Goguen Sells Shares Under 10b5-1 Trading Plan
SEC Form 4 Filing
Xometry's Chief Operating Officer, Peter Goguen, executed sales of Class A Common Stock on February 11, 2025, under a pre-arranged Rule 10b5-1 trading plan.
Summary
- On February 11, 2025, Peter Goguen, the Chief Operating Officer of Xometry, Inc. (XMTR), sold shares of Class A Common Stock.
- The sales were executed under a pre-arranged Rule 10b5-1 trading plan.
- A total of 3,000 shares were sold in two transactions.
- The first transaction involved the sale of 2,886 shares at a weighted average price of $35.5509.
- The second transaction involved the sale of 114 shares at a price of $36.1.
- Following the reported transactions, Goguen beneficially owns 161,993 shares of Class A Common Stock.
Sentiment
Score: 5
Explanation: The document is a routine SEC Form 4 filing, indicating insider selling under a pre-arranged plan. It doesn't inherently convey positive or negative sentiment, but rather reports a factual transaction.
Industry Context
Sales by company executives are a normal part of corporate governance. The use of a 10b5-1 trading plan suggests the sales were pre-planned and not based on any inside information.
Stakeholder Impact
- The sale of shares by a company executive could be perceived negatively by some shareholders, although the existence of a 10b5-1 plan mitigates this concern.
Key Dates
| Date | Description |
|---|---|
| 02/11/2025 | Date of the stock sale transactions. |
| 02/12/2025 | Date of signature for the SEC Form 4 filing. |
Keywords
Xometry, Peter Goguen, XMTR, Class A Common Stock, Rule 10b5-1, insider trading, SEC Form 4, Chief Operating Officer
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.